Hyperthyroidism is a condition characterised by an overactive thyroid gland that produces excessive amounts of thyroid hormones, leading to systemic metabolic disturbances.¹ Among its many complications, hyperthyroidism can affect the cardiovascular system, causing conditions like tachycardia, arrhythmias, and even heart enlargement.¹ This heart enlargement, known as thyrotoxic cardiomyopathy, poses significant health risks, including heart failure if left untreated.² This article explores the primary treatment strategies for managing hyperthyroidism-related heart enlargement, emphasising the importance of controlling thyroid hormone levels, addressing cardiac complications, and monitoring patient outcomes.

Understanding hyperthyroidism-related heart enlargement

Hyperthyroidism accelerates metabolic processes, increasing heart rate and contractility while reducing systemic vascular resistance.¹ Over time, these changes place significant stress on the heart, potentially causing it to enlarge as it works harder to pump blood. This condition can manifest as left ventricular hypertrophy, dilated cardiomyopathy, or, in severe cases, heart failure.³ Common symptoms include palpitations, chest pain, shortness of breath, fatigue, and swelling in advanced stages.³ Diagnosing and treating hyperthyroidism-related heart enlargement requires a multifaceted approach that combines managing thyroid dysfunction and mitigating cardiac strain.

Assessment and diagnosis

Accurate diagnosis is the cornerstone of effective treatment. Hyperthyroidism-related heart enlargement is often detected through a combination of clinical evaluations and diagnostic tests.

Clinical symptoms

Patients may report rapid heartbeat, irregular pulse, breathlessness, fatigue, and in some cases, swelling of the extremities.³ These symptoms often overlap with other cardiovascular conditions, making precise diagnostics essential.

Diagnostic tests

Blood tests are the first step, measuring thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH) levels.⁴ Hyperthyroidism is confirmed by elevated T3 and T4 levels and suppressed TSH levels.⁴ Imaging studies, such as an echocardiogram, are used to assess heart size, wall thickness, and function, helping to confirm heart enlargement. An electrocardiogram (ECG) identifies arrhythmias such as atrial fibrillation, a common complication. Additionally, a chest X-ray may reveal an enlarged cardiac silhouette. In cases where the underlying cause of hyperthyroidism needs further exploration, a thyroid scan or radioactive iodine uptake test may be conducted.⁴

Primary treatment strategies

The primary treatment for hyperthyroidism-related heart enlargement is twofold: managing the overactive thyroid and addressing cardiac complications.

Managing hyperthyroidism

The central goal in managing hyperthyroidism is to restore normal thyroid hormone levels. Several treatment modalities are available:

Antithyroid medications

Drugs such as methimazole and propylthiouracil (PTU) are commonly used to suppress thyroid hormone production. These medications inhibit thyroid peroxidase, an enzyme essential for thyroid hormone synthesis.¹ PTU has the added advantage of inhibiting peripheral conversion of T4 to T3, making it particularly useful in acute thyrotoxic states.

Beta blockers

While beta blockers do not address the underlying thyroid condition, they play a vital role in symptom control.² Propranolol and atenolol are frequently prescribed to manage tachycardia, palpitations, and anxiety. By reducing heart rate and contractility, these medications alleviate cardiac strain and improve patient comfort.

Radioactive Iodine Therapy (RAI):

RAI is a definitive treatment for hyperthyroidism. It involves the administration of radioactive iodine-131, which selectively destroys overactive thyroid tissue.³ While effective, RAI requires careful monitoring, as it may lead to hypothyroidism, necessitating lifelong thyroid hormone replacement.

Thyroidectomy

In cases where medication and RAI are ineffective or contraindicated, surgical removal of the thyroid gland may be considered.³ Thyroidectomy is also recommended for patients with large goiters compressing nearby structures or those with thyroid cancer. Post-surgery, patients typically require levothyroxine therapy to maintain normal thyroid function.

Treating cardiac symptoms

Hyperthyroidism’s cardiovascular effects often necessitate targeted interventions to protect heart function.

Rate and rhythm control

Controlling heart rate and rhythm is crucial, particularly in patients with atrial fibrillation. Beta blockers are the first-line agents for tachycardia, while antiarrhythmic drugs like amiodarone may be used for refractory arrhythmias.⁶ In severe cases, cardioversion or catheter ablation may be required.

Addressing heart failure

Heart failure, if present, is managed with standard therapies, including diuretics to relieve fluid overload and ACE inhibitors or angiotensin receptor blockers (ARBs) to support cardiac remodeling and reduce afterload.⁵ These medications not only improve symptoms but also help reverse heart enlargement over time.

Anticoagulation

Patients with atrial fibrillation face an increased risk of stroke due to blood clot formation. Anticoagulants like warfarin or direct oral anticoagulants (DOACs) are prescribed to reduce this risk, especially in patients with additional risk factors like hypertension or advanced age.⁵

Holistic and supportive care

In addition to medical interventions, lifestyle modifications and supportive measures play a vital role in the comprehensive management of hyperthyroidism-related heart enlargement.

Lifestyle modifications

Patients are advised to avoid stimulants such as caffeine and alcohol, which can exacerbate symptoms like palpitations.⁷ Stress management techniques, including yoga and mindfulness, may help reduce the overall burden on the cardiovascular system.

Nutritional support

Hyperthyroidism increases metabolic demands, requiring a high-calorie diet to prevent unintended weight loss and muscle wasting.⁷ In some cases, patients may be advised to avoid iodine-rich foods, such as seaweed and iodised salt, to prevent exacerbation of thyroid overactivity.

Monitoring and follow-up

Regular monitoring is essential to assess treatment efficacy and ensure patient safety.

Thyroid function tests

Frequent blood tests are conducted to track thyroid hormone levels and adjust treatment accordingly.⁸ This is particularly important during the transition from hyperthyroid to euthyroid or hypothyroid states.

Cardiac monitoring

Follow-up echocardiograms are used to evaluate changes in heart size and function.⁸ Improvement in left ventricular function or reduction in cardiac dimensions typically indicates successful management of hyperthyroidism.

Adjusting treatment

Medications may need to be tapered or adjusted based on clinical response and side effects.⁸ For example, beta blockers may be discontinued once thyroid hormone levels normalise and cardiac symptoms resolve.

Addressing complications

Despite optimal treatment, complications may arise and require advanced interventions.

Persistent arrhythmias

If arrhythmias persist despite medication, advanced treatments like catheter ablation or implantation of a pacemaker may be necessary.⁵

Progression of heart failure

In cases where heart failure worsens, intensification of therapy with higher doses of diuretics, additional vasodilators, or even advanced devices like implantable defibrillators may be required.⁵

Hypothyroidism post-treatment

RAI and thyroidectomy often lead to hypothyroidism, requiring lifelong thyroid hormone replacement therapy.⁵ Levothyroxine dosing must be carefully calibrated to avoid under- or overtreatment, which could further affect cardiac health.

Summary

The management of hyperthyroidism-related heart enlargement requires a multidisciplinary approach that combines endocrinology and cardiology expertise. By controlling thyroid dysfunction, addressing cardiac complications, and providing holistic care, it is possible to reverse heart enlargement and improve patient outcomes. Regular monitoring and timely intervention are critical to prevent complications and ensure long-term health. With appropriate treatment, most patients experience significant improvement in both thyroid function and cardiac health, underscoring the importance of early diagnosis and comprehensive care.